SAN CARLOS, CA / ACCESS Newswire / May 11, 2026 / Form Bio, a leader in AI-powered genetic medicine development and genome engineering, today announced the launch of FormManufacturing™, a new platform ...

An emphasis on emotional depth and cultural nuance within the design process is among the priorities in creative education, ...

Good afternoon, everyone, and thank you for joining us today to discuss Kyntra Bio, Inc.’s first quarter 2026 financial and business results. I am Gaia Vasiliver-Shamis from LifeSci Advisors. Joining ...

Adaptin Bio, Inc. (OTCQB: APTN), (“Adaptin” or the “Company”), a biotechnology company developing precision cancer ...

Kyntra Bio, Inc. (NASDAQ: KYNB) Q1 2026 Earnings Call Transcript May 11, 2026 Kyntra Bio, Inc. misses on earnings expectations. Reported EPS is $-3.76 EPS, expectations were $-3.36.

First Reporting Quarter as Valion Bio Marked by Continued Advancement of the Entolimod Platform, Broader Government Engagement, and Continued Integration of Velocity ...

Compared with Q4 2025, management’s interim-readout language shifted from “the second half of 2026” to “the fourth quarter of 2026,” with CEO Wettig now stating “we are on track for the interim ...

Arun Nathani, CEO and Managing Director of Cybage Software, a global leader in Digital Engineering Services, Analytics, and Enterprise Solutions, founded the co ...

The chips that datacenters use to run the latest AI breakthroughs generate much more heat than previous generations of silicon. Anybody whose phone or laptop has overheated knows that electronics ...

Preconditioning-free (PC-free) 6-to-9-month clinical data with a single infusion of the lowest dose of rese-cel in the RESET-PV® study presented today at ASGCT 2026 Annual Meeting along with initial ...

A small model with a visual feedback loopAt the core of the system is Bioinspired3D, a 3-billion-parameter language model fine-tuned on a curated ...

Enrollment on track for Phase 3 UPSTREAM MG trial of telitacicept in generalized myasthenia gravis patients with topline results anticipated in 1H27 Enrollment ongoing for Phase 3 UPSTREAM SjD of teli ...